Affiliations 

  • 1 Chulalongkorn Centre of Excellence for Parkinson's Disease and Related Disorders, Department of Medicine, Faculty of Medicine Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society Bangkok Thailand
  • 2 Division of Neurology, Department of Medicine, Faculty of Medicine University of Malaya Kuala Lumpur Malaysia
  • 3 Department of Neurology National Institute of Mental Health & Neurosciences (NIMHANS) Bengaluru India
  • 4 Department of Neurology Seoul Metropolitan Government-Seoul National University Boramae Medical Center & Seoul National University College of Medicine Seoul Republic of Korea
  • 5 Center for Parkinson's Disease and Movement Disorders Manipal Hospital Bangalore India
  • 6 Department of Neurology, Fukuoka University, Faculty of Medicine Fukuoka Japan
  • 7 Department of Neurology, Laboratory of Neurodegenerative Disorders, Rare Diseases Center West China Hospital, Sichuan University Chengdu China
  • 8 Neurology Unit, Department of Medicine, Faculty of Medicine Universiti Kebangsaan Malaysia Kuala Lumpur Malaysia
  • 9 Deprtment of Human Neurophysiology, Faculty of Medicine Fukushima Medical University Fukushima Japan
  • 10 Neurology Unit, King Fahad Military Medical Complex Dhahran Saudi Arabia
  • 11 Department of Neurology Seoul National University College of Medicine Seoul Republic of Korea
  • 12 Section of Neurology, Department of Neuroscience Makati Medical Center, NCR Makati Philippines
  • 13 I. K. Akhunbaev Kyrgyz State Medical Academy Bishkek Kyrgyzstan
  • 14 Department of Neurology National Taiwan University Hospital Taipei Taiwan
Mov Disord Clin Pract, 2023 Jun;10(6):878-895.
PMID: 37332644 DOI: 10.1002/mdc3.13737

Abstract

The increasing availability of molecular genetic testing has changed the landscape of both genetic research and clinical practice. Not only is the pace of discovery of novel disease-causing genes accelerating but also the phenotypic spectra associated with previously known genes are expanding. These advancements lead to the awareness that some genetic movement disorders may cluster in certain ethnic populations and genetic pleiotropy may result in unique clinical presentations in specific ethnic groups. Thus, the characteristics, genetics and risk factors of movement disorders may differ between populations. Recognition of a particular clinical phenotype, combined with information about the ethnic origin of patients could lead to early and correct diagnosis and assist the development of future personalized medicine for patients with these disorders. Here, the Movement Disorders in Asia Task Force sought to review genetic movement disorders that are commonly seen in Asia, including Wilson's disease, spinocerebellar ataxias (SCA) types 12, 31, and 36, Gerstmann-Sträussler-Scheinker disease, PLA2G6-related parkinsonism, adult-onset neuronal intranuclear inclusion disease (NIID), and paroxysmal kinesigenic dyskinesia. We also review common disorders seen worldwide with specific mutations or presentations that occur frequently in Asians.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.